Evolution of the Amyotrophic Lateral Sclerosis Diagnostic Criteria Towards the Gold Coast Criteria
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disorder characterized by progressive degeneration of upper and lower motor neurons (LMNs). Careful history taking, neurological examination, and electromyography are used to confirm its clinical diagnosis. The El Escorial, revised El Escorial and Awaji criteria have proposed varying degrees of diagnostic probability for ALS. However, such categories may cause uncertainty among patients regarding the certainty of diagnosis. Cases labeled as “possible ALS” also risk exclusion from clinical trials. To clarify and simplify the diagnostic criteria of ALS, the previous diagnostic categories of possible, probable, and definite were abandoned in the newly suggested criteria, Gold Coast criteria. The simplified criteria offer practical utility for precise diagnosis of LMN-predominant ALS and clinical trial recruitment going forward.
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disorder characterized by progressive degeneration of upper and lower motor neurons (LMNs). Careful history taking, neurological examination, and electromyography are used to confirm its clinical diagnosis. The El Escorial, revised El Escorial and Awaji criteria have proposed varying degrees of diagnostic probability for ALS. However, such categories may cause uncertainty among patients regarding the certainty of diagnosis. Cases labeled as “possible ALS” also risk exclusion from clinical trials. To clarify and simplify the diagnostic criteria of ALS, the previous diagnostic categories of possible, probable, and definite were abandoned in the newly suggested criteria, Gold Coast criteria. The simplified criteria offer practical utility for precise diagnosis of LMN-predominant ALS and clinical trial recruitment going forward.
참고문헌 (27)
- Kiernan MC, "Amyotrophic lateral sclerosis", Lancet, 377, pp.942~955 (2011)
- Al-Chalabi A, "The epidemiology of ALS: a conspiracy of genes, environment and time", Nat Rev Neurol, 9, pp.617~628 (2013)
- Brooks BR, "El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases", Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors, 1994, pp.124(Suppl), 96~107
- Turner MR, "The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey", J Neurol Neurosurg Psychiatry, 86, pp.667~673 (2015)
- Ince PG, "Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS", Neurology, 60, pp.1252~1258 (2003)
- Kim WK, "Study of 962 patients indicates progressive muscular atrophy is a form of ALS", Neurology, 73, pp.1686~1692 (2009)
- Riku Y, "Differential motor neuron involvement in progressive muscular atrophy : a comparative study with amyotrophic lateral sclerosis", BMJ Open, 4, pp.e005213~ (2014)
- Phukan J, "Cognitive impairment in amyotrophic lateral sclerosis", Lancet Neurol, 6, pp.994~1003 (2007)
- Lambert EH, "Electromyographic studies in amyotrophic lateral sclerosis", Proc Staff Meet Mayo Clin, 32, pp.441~446 (1957)
- Dumitru D, "Electrodiagnostic medicine" (1995), Hanley and Belfus
- Douglass CP, "An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease", J Neurol Neurosurg Psychiatry, 81, pp.646~649 (2010)
- Behnia M, "Role of electromyography in amyotrophic lateral sclerosis", Muscle Nerve, 14, pp.1236~1241 (1991)
- Traynor BJ, "Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study", Arch Neurol, 57, pp.1171~1176 (2000)
- de Carvalho M, "Electrodiagnostic criteria for diagnosis of ALS", Clin Neurophysiol, 119, pp.497~503 (2008)
- Brooks BR, "World Federation of Neurology Research Group on Motor Neuron Diseases: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis", Amyotroph Lateral Scler Other Motor Neuron Disord, 1, pp.293~299 (2000)
- Ross MA, "Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group", Neurology, 50, pp.768~772 (1998)
- Eisen A, "Clinical electromyography", pp.424~450 (1993), Butterworth-Heinemann
- Turner MR, "Biomarkers in amyotrophic lateral sclerosis", Lancet Neurol, 8, pp.94~109 (2009)
- Siddique T, "Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity", N Engl J Med, 324, pp.1381~1384 (1991)
- Zoccolella S, "Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients : a population-based study", J Neurol Sci, 250, pp.45~49 (2006)
- Higashihara M, "Fasciculation potentials in amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm", Muscle Nerve, 45, pp.175~182 (2012)
- Hannaford A, "Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis", Ann Neurol, 89, pp.979~986 (2021)
- Johnsen B, "Diagnostic criteria for amyotrophic lateral sclerosis : a multicentre study of inter-rater variation and sensitivity", Clin Neurophysiol, 130, pp.307~314 (2019)
- Strong MJ, "Amyotrophic lateral sclerosis-frontotemporal spectrum disorder(ALS-FTSD) : revised diagnostic criteria", Amyotroph Lateral Scler Frontotemporal Degener, 18, pp.153~174 (2017)
- Benatar M, "Neurofilaments in pre-symptomatic ALS and the impact of genotype", Amyotroph Lateral Scler Frontotemporal Degener, 20, pp.538~548 (2019)
- Shefner JM, "A proposal for new diagnostic criteria for ALS", Clin Neurophysiol, 131, pp.1975~1978 (2020)
- Shen D, "The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population", Transl Neurodegener, 10, pp.28~ (2021)